22nd Century Group, Inc. (XXII)
| Market Cap | 8.15M |
| Revenue (ttm) | 82.41M |
| Net Income (ttm) | -138.66M |
| Shares Out | 43.78M |
| EPS (ttm) | -8.23 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,811,776 |
| Open | 0.195 |
| Previous Close | 0.192 |
| Day's Range | 0.175 - 0.195 |
| 52-Week Range | 0.162 - 18.975 |
| Beta | 1.58 |
| Analysts | Buy |
| Price Target | 5.00 (+2,585.29%) |
| Earnings Date | Nov 6, 2023 |
About XXII
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and ot... [Read more]
Financial Performance
In 2022, XXII's revenue was $62.11 million, an increase of 100.69% compared to the previous year's $30.95 million. Losses were -$59.80 million, 83.4% more than in 2021.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for XXII stock is "Buy." The 12-month stock price forecast is $5.0, which is an increase of 2,585.29% from the latest price.
News
22nd Century Group Completes Sale of Hemp/Cannabis Franchise
Sale Will Significantly Reduce Operating Expenses, Ultimately Reduce Debt by $5.2 Million Buffalo, New York--(Newsfile Corp. - December 28, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Compan...
22nd Century Group's Senior Lender Approves Sale of Hemp/Cannabis Franchise on Improved Terms
Sale and Related Actions Ultimately Expected to Reduce Debt Principal by $5.2 Million Buffalo, New York--(Newsfile Corp. - December 14, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" o...
22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction
Newly Appointed CEO Leading Restructuring to Focus on Tobacco Industry Operations, Reduce Costs Newly Appointed CEO Leading Restructuring to Focus on Tobacco Industry Operations, Reduce Costs
22nd Century Appoints Larry Firestone as Chairman and CEO
Turnaround Veteran to Focus on Unlocking Shareholder Value in Tobacco Assets Turnaround Veteran to Focus on Unlocking Shareholder Value in Tobacco Assets
Top 5 Risk Off Stocks Which Could Rescue Your Portfolio This Month - Planet Green Holdings (AMEX:PLAG), Calavo Growers (NASDAQ:CVGW)
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise
Sale Expected to Result in Immediate and Significant Reduction in Operating Costs and Cash Requirements Sale Expected to Result in Immediate and Significant Reduction in Operating Costs and Cash Requi...
Top 4 Risk Off Stocks You'll Regret Missing In Q4 - The Real Good Food (NASDAQ:RGF), Albertsons Companies (NYSE:ACI)
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores
BUFFALO, N.Y., Nov. 08, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellne...
22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License
Additional Exclusive License with NCSU Further Expands Reduced Nicotine Content Plant Breeding Capabilities Additional Exclusive License with NCSU Further Expands Reduced Nicotine Content Plant Breedi...
22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results
BUFFALO, N.Y., Nov. 06, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellnes...
22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB
BUFFALO, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellne...
22nd Century Group (XXII) Reduces Debt by $8.1 Million
37% Reduction Through the Transfer of Non-Core and Previously Restricted Assets 37% Reduction Through the Transfer of Non-Core and Previously Restricted Assets
22nd Century Announces Pricing of $5.25 Million Public Offering
BUFFALO, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, h...
22nd Century Announces Proposed Public Offering
BUFFALO, N.Y., Oct. 16, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, h...
22nd Century Group (XXII) Adds 1,200 Drug Store Locations Selling VLN® in Five States
First Drug Store Channel Retail Chain Begins VLN® Sales in September, Continues to Book Additional Launches for Rest of 2023 First Drug Store Channel Retail Chain Begins VLN® Sales in September, Conti...
22nd Century Group Initiates Strategic Alternatives Process for Its Tobacco Assets
BUFFALO, N.Y., Sept. 05, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ: XXII) (the “Company”) today announced that its Board of Directors, after consultation with its financial and legal a...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 22nd Century Group, Inc. - XXII
NEW YORK,, Aug. 18, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of 22nd Century Group, Inc. ("22nd Century" or the "Company") (NASDAQ: XXII). Such investors are a...
22nd Century Group (XXII) Reports Second Quarter 2023 Financial Results
BUFFALO, N.Y., Aug. 14, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellnes...
22nd Century Group (XXII) Updates Second Quarter 2023 Results Webcast Time on August 14, 2023
BUFFALO, N.Y., Aug. 09, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis an...
22nd Century Group (Nasdaq: XXII) to Announce Second Quarter 2023 Results on August 14, 2023
BUFFALO, N.Y., Aug. 07, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis an...
22nd Century Announces Executive Leadership Changes
Expands Board with New Highly Accomplished Independent Director Strengthens Balance Sheet and Implements $15 Million Cost Reduction Initiative BUFFALO, N.Y., July 24, 2023 (GLOBE NEWSWIRE) -- 22nd Cen...
22nd Century Group (XXII) Regains Compliance with Nasdaq Listing Standards
BUFFALO, N.Y., July 20, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellne...
A Cigarette to Help Californians Smoke Less: 22nd Century Group, Inc. Launches Reduced Nicotine VLN® King Cigarettes in California, VLN Will Be Sold at #1 U.S. Convenience Store Chain and Other Responsible Retail Locations
With 95% less nicotine than a traditional cigarette, VLN® cigarettes help existing adult smokers reduce their nicotine consumption and dependence With 95% less nicotine than a traditional cigarette, V...
22nd Century Group (XXII) VLN® Products Now Selling in Montana C-Stores
Town Pump, #1 Chain in Montana, Selling VLN® Products in More Than 80 Stores Across the State
22nd Century Group (XXII) Announces New Agreement with Hub, Inc. to Expand Midwest Distribution
BUFFALO, N.Y., July 12, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellne...